Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
about
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Acquired Inhibitors to Multiple Coagulation Factors (V, IX, and XII) Identified in a Unique Patient with Hepatocellular Carcinoma.Acquired factor v inhibitor developing after treatment with dabigatran etexilate methanesulfonate: a case report and review of the literatureRenal injury and the application of polysaccharide hemospheres: a laparoscopic experimental model.Characterization of the biological effect of fish fibrin glue in experiments on rats: immunological and coagulation studiesAcquired inhibitor of factor V: first report in China and literature review.Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.Acquired coagulation inhibitor-associated bleeding disorders: an update.Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literatureBleeding associated with acquired factor V inhibitor in a patient on warfarin treated successfully with prednisolone.Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study.Exogenous bovine thrombin as a biomarker of exposure and outcome.Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety.Achieving hemostasis in the surgical field.Clinical use of topical thrombin as a surgical hemostat.Development of cephradine-induced acquired factor V inhibitors: a case report.Acquired factor V inhibitors: a systematic review.Thrombin use in surgery: an evidence-based review of its clinical use.Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case report.Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature.Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure.Acquired factor V inhibitor associated with valproic acid use in a cirrhotic patient.A case of an asymptomatic idiopathic inhibitor to coagulation factor V.Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.A Case of Intraoperative Anaphylaxis Caused by Bovine-Derived Thrombin.Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications.
P2860
Q30276550-3E2B7D11-B3C5-4FC2-9D3C-23A0DF3E0DC1Q32182224-F32BF77C-6A57-4DD5-8C00-2AB39743AD0BQ34316233-8831C80F-0CF6-4ED3-B892-484A87A8C851Q34374779-FA97AEFC-F532-4FF5-9FF4-2F78F582B7DAQ35533347-794A993B-F4E7-41C7-A19A-91A7264BBFA1Q35882787-B110C98F-A6BC-4263-AE93-8E17ACD498E5Q36187384-BEFF9560-4173-40EB-976F-64A8EDA861FCQ36328387-022DA61E-04AD-4B44-8D25-BC050E2324B3Q36512498-8D3DFA12-186E-4E5A-83F9-30681FBADC3DQ37144943-328CCB57-70F6-4937-8764-042DD2ED2401Q37265091-0110992C-EE5C-458B-B962-E8186F2A817CQ37266500-6B7E20A5-E210-4469-81F1-A464C3FB023CQ37492672-AEB63676-06AF-4054-AA7C-9D5D5EA0A309Q37532508-37AE677E-04EC-477F-ACC6-863700082E39Q37586947-2100328D-096A-48EB-8A4A-D5A3EBD82DBDQ37784350-C166C23D-4131-4261-974F-5A21D033BC96Q37807275-3D3A3694-8FAD-4415-A434-5C013F2BAC7FQ37979181-CDAD4B52-2987-4F4F-8FA5-A30D32621B59Q38193071-96DD580E-5E6C-4BD0-B616-4516ADC0A1DAQ38490543-18C07E32-24E0-4313-9BED-59BEF2E92318Q38565993-E849AA31-1321-4337-B13E-2C59E8431FFAQ42844307-A1C82921-E536-47CD-8193-22BC82FA64F2Q45882497-169EE840-EEDA-4EA7-861A-E5EE5967134DQ46411395-CC923048-2DEF-411A-A5D8-DAB068EF4177Q50144854-B7E39902-EB75-493B-91D9-375C20DEFFFBQ51135382-59EB691E-1396-479B-A82D-69CD46FD8148
P2860
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@ast
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@en
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@nl
type
label
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@ast
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@en
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@nl
prefLabel
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@ast
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@en
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@nl
P2860
P1433
P1476
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
@en
P2093
Michael B Streiff
Paul M Ness
P2860
P356
10.1046/J.1537-2995.2002.00011.X
P577
2002-01-01T00:00:00Z